The global kyphoplasty market is expected to reach USD 3,269.5 million by 2028, expanding at a CAGR 12.7% during the forecast period, 2021-2028. According to the International Osteoporosis Foundation, around 8.9 million fractures occur globally each year. Additionally, industry participants' technical breakthroughs and restrictions associated with traditional methodologies are expected to drive the market growth.

Market Drivers, Restraints, and Opportunities
- Increasing prevalence of osteoporosis and geriatric population is estimated to drive the market growth.
- Growing prevalence of osteoporosis is anticipated to fuel the growth of the kyphoplasty market.
- The rise in the number of obese population is one of the major factors that can foster the growth of the market during the forecast period.
- Rising demand for minimally invasive surgical procedures is expected to drive the demand for kyphoplasty in the coming years.
- Rising technical advancements drive global market growth.
- High prices of minimally invasive ablation operations limit the market's scope for the growth.
- Stringent restrictions governing the approval and clearance of kyphoplasty technologies can restrain the market expansion.
- The potential of cement leakage that can harm the surrounding nerves is a huge hurdle for the market.
- Changes in lifestyle due to frantic and busy schedule have exacerbated spinal difficulties as a result of incorrect posture, lengthy sitting hours, and an unhealthy diet. According to the International Osteoporosis Foundation (IOF), one in every three women over the age of 50 and one in every five males can develop osteoporotic fractures in their lifetime. Thus, such factors can create lucrative opportunities for the market.
Scope of Kyphoplasty Market Report
The report on the global kyphoplasty market includes an assessment of the market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast.
Attributes
|
Details
|
Report Title
|
Kyphoplasty Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018–2019
|
Forecast Period
|
2021–2028
|
Segmentation
|
Types (Balloon, Cement Mixing, Needle, X-ray Devices, and Delivery Devices) Applications (Kyphosis, Spinal Fractures, and Vertebral Alignment) End-users (Hospitals, Clinics, and Ambulatory Surgical Centers)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Stryker Corporation, Medtronic, BMK Global Medical Company, CareFusion, Taeyeon Medical Co., Ltd, DePuy Synthes (Johnson & Johnson Services, Inc.), iMEDICOM, Alphatec Spine, Inc., Osseon LLC, G21 Srl, Smith + Nephew, and Zimmer Biomet
|
Kyphoplasty Market Segment Insights
Balloon segment to hold a major market share
Based on product types, the market can be segmented into balloon, cement mixing, needle, x-ray devices, and delivery devices The balloon segment is anticipated to hold a large market share owing to growing technological advancements with initiation of next generation kyphoplasty balloons such as Arcadia by Merit Medical and Kyphon Express II by Medtronic (2014), enabling efficient procedures in the market.
Spinal fractures segment to dominate the market during the forecast period
On the basis of applications, the kyphoplasty market can be classified as kyphosis, spinal fractures, and vertebral alignment) end-users (hospitals, clinics, and ambulatory surgical centers. The spinal fractures segment is estimated to dominate the market during the forecast period. In 2020, the spinal fractures segment accounted for over 40% market share.
Surging cases of road accidents and prevalence of spine related problems results into the demand for spinal fracture procedure. According to the United States Bone and Joint Initiative, around 36,000 traumatic spine fractures occur each year.

Hospitals segment to exhibit a high CAGR
In terms of end-users, the market can be segregated into hospitals, clinics, and ambulatory surgical centers. The hospital segment is estimated to hold a major market share and is estimated to grow at a high rate during the forecast period. The presence of reimbursement policies is driving the growth of the market segment.
North America to constitute a major market share
Based on regions, the kyphoplasty market can be categorized as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa North America is estimated to hold a large market share during the forecast period due to increased healthcare IT investment in countries such as the US and Canada.
Furthermore, the region's dominance is due to the presence of well-established firms as well as the most recent technologically advanced products and services. The market in Asia Pacific is expected to grow at a healthy rate due to fast developing healthcare infrastructure and widespread acceptance of new technology in emerging economies such as India and China.

Segments
By Product types
- Balloon
- Cement Mixing
- Needle
- X-Ray Device
- Delivery Devices
By Applications
- Kyphosis
- Spinal Fractures
- Vertebral Alignment
By End-users
- Hospitals
- Clinics
- Ambulatory Surgical Centers
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
By Key Players
- Stryker Corporation
- Medtronic
- BMK Global Medical Company
- CareFusion
- Taeyeon Medical Co., Ltd
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- iMEDICOM
- Alphatec Spine, Inc.
- Osseon LLC
- G21 Srl
- Smith + Nephew
- Zimmer Biomet
Competitive Landscape
The major kyphoplasty market players include Stryker Corporation, Medtronic, BMK Global Medical Company, CareFusion, Taeyeon Medical Co., Ltd, DePuy Synthes (Johnson & Johnson Services, Inc.), iMEDICOM, Alphatec Spine, Inc., Osseon LLC, G21 Srl, Smith + Nephew, and Zimmer Biomet.
To remain competitive in the fast-developing kyphoplasty market, these firms are implementing a variety of strategic efforts like as new product releases and collaborations. For example, Medtronic launched its Kyphon Assist Directional Cannula in the US in May 2020 to supplement its other kyphoplasty products for the treatment of spinal compression fractures caused by osteoporosis, benign lesions, or cancer.
